420 mg (14 mL)/vial. Each vial contains 14 mL of concentrate at 30 mg/mL, containing 4
Perjeta (pertuzumab injection) 420mg (14mL)
Pertuzumab Injection
A public medicine summary is being prepared.
Public medicine directory
Antineoplastic and Immunomodulating Agents
Browse public medicine summaries, manufacturers, and approval information for Antineoplastic and Immunomodulating Agents.
1653 medicinesPage 106 of 138
420 mg (14 mL)/vial. Each vial contains 14 mL of concentrate at 30 mg/mL, containing 420 mg of
Perjeta (pertuzumab injection) 420mg
Pertuzumab Injection
A public medicine summary is being prepared.
420 mg (14 mL)/vial
Perjeta (pertuzumab injection) 420mg
Pertuzumab Injection
A public medicine summary is being prepared.
420 mg (14 mL)/vial. Each vial contains 14 mL of concentrate at 30 mg/mL, containing 420 mg of